COPD clinical trials in Michigan
22 studies for COPD are looking for participants at sites in Michigan.
Cities in Michigan
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Revive Research Institute, Inc., Southfield
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- University of Michigan Health System - Ann Arbor- Site Number : 8400090, Ann Arbor
- Veritas Clinical Research- Site Number : 8400007, Madison Heights
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Henry Ford Hospital, Detroit
Recruiting
Ages 40 to 80 · All sexes · Updated Sep 17, 2026 · NCT06035120Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Vitalis Clinical Research Center- Site Number : 8400040, Allen Park
- Bolt Clinical Research- Site Number : 8400086, Brighton
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Farmington Hills
- Research Site, Garden City
- Research Site, Grand Rapids
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Michigan, Ann Arbor
- Henry Ford Health, Detroit
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Ann Arbor
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Farmington Hills
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Revival Research Institute, LLC, Dearborn
- AA Medical Research Center, Flint
- Revive Research Institute, Inc., Southfield
- and 1 more
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Ann Arbor
- Research Site, Flint
- Research Site, Southfield
- and 1 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Aug 26, 2026 · NCT06283966Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Michigan, Ann Arbor
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Jul 31, 2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Allen Park
- GSK Investigational Site, Clarkston
- GSK Investigational Site, Dearborn
RecruitingPhase 3
Ages 40 to 75 · All sexes · Updated Jul 28, 2026 · NCT07177339Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- John D. Dingell VA Medical Center, Detroit, MI, Detroit
Recruiting
Ages 60 and older · All sexes · Updated Jun 5, 2026 · NCT04179981SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Michigan, Ann Arbor
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 55 · All sexes · Updated Jun 3, 2026 · NCT05033990Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- John D. Dingell VA Medical Center, Detroit, MI, Detroit
Recruiting
Ages 60 to 89 · All sexes · Updated May 26, 2026 · NCT02703207Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated May 13, 2026 · NCT05270525Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Henry Ford Hospital - Lung and Pulmonary Care, Detroit
Recruiting
Ages 40 to 80 · All sexes · Updated Apr 28, 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Michigan, Ann Arbor
Recruiting
Ages 40 to 84 · All sexes · Updated Apr 24, 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Allen Park
- GSK Investigational Site, Detroit
- GSK Investigational Site, Garden City
- and 1 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Apr 9, 2026 · NCT06961214University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 50 to 80 · All sexes · Updated Mar 25, 2026 · NCT07482475Supporting Evidence-based Responses to Emotional Needs in Emphysema
- Henry Ford Health System, Detroit
Recruiting
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT06600126myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Henry Ford Health, Detroit
Recruiting
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.